Synlogic Inc Stock price
Is Synlogic Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.
Key metrics
Synlogic Inc Stock Analysis
Analyst Opinions
6 Analysts have issued a Synlogic Inc forecast:
Analyst Opinions
6 Analysts have issued a Synlogic Inc forecast:
Synlogic Inc Events
Past Events
|
NOV
11
Q3 2026 Earnings Call
2 days ago
|
Don't miss a Thing! We will send you all news about Synlogic Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Synlogic Inc Stock News
Company Profile
Synlogic, Inc. is a clinical-stage biopharmaceutical company. It engages in drug discovery and development of synthetic biotic medicines. The firm focuses on SYNB1020 and SYNB1618, which are orally administered and target hyperammonemia and phenylketonuria. It also works on SYNB1891, an intratumorally administered which treats cancer. The company was founded by Jim Collins and Tim Lu on August 28, 2017, and is headquartered in Cambridge, MA.
| Head office | United States |
| CEO | Mary Dooley |
| Employees | 1 |
| Founded | 2017 |
| Website | www.synlogictx.com |


